chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PATIENT complained that her whole hand was turning NUMB and she was not able to feel anything - but when she pinches herself then she feels it. and she is having tingling sensation in her entire left arm, where she got the vaccine, which did not happen during the 1st two doses that she received.
Patient has an itchy reaction & cannot stop scratching. The site is not swollen or inflamed. This is one day after shot.
Reddened, warm area to upper left arm. Treated with Benadryl and Motrin PRN.
There is no adverse events. Pt received vaccine out of licensure. Pt had Hib #1 after the age of 1 and didn't need a fourth one.
Information has been received from a nurse concerning a patient who on 20-DEC-2007 was vaccinated with her third dose GARDASIL (lot# unspecified). On 20-DEC-2007 the patient experienced persistent pain at the injection site of the right deltoid. The patient experiences pain at the injection site only when the right arm is raised to shoulder level. The patient's pain at the injection site of the right deltoid persisted. No treatment has been initiated. The reporter felt that persistent pain at the injection site of the right deltoid muscle was not related to therapy with GARDASIL. Additional information has been requested.
Patient developed wheezing and facial flushing/itching. Treated with albuterol, intramuscular diphenhydramine and oral dexamethasone. Patient was discharged from the ER without further complication. Has received influenza vaccine in past.
Client vaccinated at 6:30pm on 4/10/2021 During 15 mins observation. Someone yelled stating that client fell. Upon arrival, RN noted that client face was very dusky and pale.  She was assisted by other providers to lie down on her back and legs elevated. BP 132/79 P 86, O2 86%,  RN noted carpal spasm started on right arm and then to left arm. 911 called, Fire Department arrived O2 applied.  BP 128/81 P105, O2 95%  Client went to Hospital via ambulance.
The patient received the first dose on 10/20/18. On 11/03/2018, patient came to the pharmacy to receive a VALTREX script to treat the shingles virus. Patient experienced the shingles virus in the middle of his forehead. After speaking with the patient, he stated that the virus lasted for about 10 days until it was clear.
Information regarding Prevenar (pneumococcal 7-valent conjugate vaccine (diphtheria crm197 protein) injection) was received from a father regarding his 12 year old son who was messed up due to vaccine. The patient received a dose on an unspecified date. Relevant medical history was not provided. The indication for Prevnar was immunization. The product was administered on an unspecified date. Dose regimen was 1 dose 1 time per day. Concomitant medications were not reported. The reporter described his son as messed up because of the vaccines he got (unevaluable event). No additional information was available at the time of this report. This is one of two patients who experienced this event following receipt of Prevnar. See related case HQWYE501716JUN05.
Flu-like symptoms.  Weak/malaise.  Joint pain and Muscle fatigue/soreness with Headache.  Redness/swelling at site (subcutaneous, over the left deltoid) with defined "head".  Swelling/redness extends 2-3 inches beyond injection site and is marked for future observation.  I am self-medicating with beer at this time... :-)  Will follow up with Medical Clinic on 17OCT2008 if redness extends beyond markings.  This is the first time that I have had a reaction this severe for this type of vaccination (Anthrax).  This is my 11th Anthrax vaccine.  I am a certified Allergy/Immunizations Technician and attended the Medical Center's Allergy/Immunization Course in 2003.  I can be reached via the phone number listed or by email. Thank you!
30 seconds after the immunization was given the patient fainted. She was unconscious for less than 10 second. She did not hit her head or have any other trauma.
Presented with worsening shortness of breath and minimal cough and constant chest pressure. Being seen at the local hospital for lung transplant due to his interstitial lung disease. He is on 8 L of oxygen at home and when he arrived at the emergency department was requiring 15 L non-rebreather. Admitted with a working diagnosis of acute on chronic hypoxic respiratory failure due to COVID-19 pneumonia superimposed on interstitial lung disease awaiting lung transplant and Gram-negative pneumonia. Patient was admitted to the ICU and was eventually intubated due to worsening respiratory failure. He was on antibiotics and seen by infectious disease. TX: remdesivir, ABX, Actemra, IV steroids, trach. Developed hypotension & septic shock. Palliative care consulted due to multiple organ failure & family opted for comfort care. Expired.
Fever; Bodyache; Headache; he was thinking that perhaps he got Covid from wife; This is a spontaneous report from a contactable consumer (patient). A 62-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Batch/Lot Number: ER8730; Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 26Mar2021 (at the age of 62-years-old) as DOSE 1, SINGLE for covid-19 immunisation. Patient got vaccine at a mass vaccination site at (park name) and stated that he didn't know the mailing address of Physician. Consumer stated the time 10:30 A.M when probed for expiration date. Medical history included heart disease from an unknown date and unknown if ongoing, had 2 heart attacks, 4 stents and open-heart surgery on an unknown date. Had open-heart surgery 16 years ago and then stent and heart attack were like 8, 9 years ago. The patient's concomitant medications were not reported. The patient experienced fever, bodyache, headache on an unspecified date. Investigation assessment included none. Consumer stated that he got Pfizer vaccine on 26th and on the next 2 days had side effects and then realized that they were side effect. Then his wife tested positive for corona virus. She had been in another room in isolation, and patient was very far away from her and did not have contact. Consumer stated his wife was tested positive for Covid, and if he should get tested for Covid. On paraphrasing concern, consumer stated, he was thinking that perhaps he got Covid from wife, even though they had been 60 feet apart whole time. When probed for the date of event, consumer stated as 27th and 28th and felt much better on the day of this report (further clarification unknown). Clinical outcome of events was recovering.  No follow-up attempts are possible. No further information is excepted.
Employee called with positive test results on 8/22/21. Advised to isolate and update mgmt. has not yet been contacted. Onset of symptoms started on 8/20/21. Isolation until 8/30/21. Last day of work 7/30/21. Sick day on 8/24/21. did not participate in the study but would like the antibody test. Scheduled testing. Advised that she can get tested after her isolation period is over.
arm is about 2inches diameter; itchy, itchy, itchy; redness and itchiness around the injection site; redness and itchiness around the injection site; soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness and itchiness around the injection site), VACCINATION SITE PRURITUS (redness and itchiness around the injection site), VACCINATION SITE REACTION (arm is about 2inches diameter), PAIN (soreness) and PRURITUS (itchy, itchy, itchy) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness and itchiness around the injection site), VACCINATION SITE PRURITUS (redness and itchiness around the injection site) and PAIN (soreness). On 22-Jan-2021, the patient experienced VACCINATION SITE REACTION (arm is about 2inches diameter) and PRURITUS (itchy, itchy, itchy). The patient was treated with HYDROCORTISONE (topical) in January 2021 for Adverse event, at a dose of UNK dosage form. On 18-Jan-2021, PAIN (soreness) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (redness and itchiness around the injection site), VACCINATION SITE PRURITUS (redness and itchiness around the injection site), VACCINATION SITE REACTION (arm is about 2inches diameter) and PRURITUS (itchy, itchy, itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided by the reporter.     Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: outcome of events changed to resolved
Patient suffered the first of two ischemic strokes on 10/02/2021. The second stroke was 12/01/2021. She had no history of hypercoaguability or embolic events. No artheriosclerosis. At the time, she was on hiatus from immunotherapy for lung cancer after having a complete response 07/21 to stage IV occurrence diagnosed 10/2019. Symptoms from Stroke One resolved gradually, but the second was accompanied by facial droop, slurred speech and L sided weakness. It was diagnosed as an acute bilateral ischemic stroke.
Information has been received from an approximately 19 year old female medical technician with no known drug allergy or pertinent medical history reporting on herself. In 1996 (at the age about 10 years), the patient received 3 doses of RECOMBIVAX HB (lot #, route, injection site and date for each dose not reported). She went to doctor in 2005 and had a titer done and was informed that she was not protected. The doctor gave her another 3 injection of RECOMBIVAX HB (lot #, route, injection site and date for each dose not reported) in 2005 (at the age about 19 years). The patient had another titer done 6 months after the third injection and again she did not have immunity. Additional information has been requested. This is one of several reports received from a same source.
Received a booster shot from an expired lot; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a booster shot from an expired lot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a booster shot from an expired lot). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Received a booster shot from an expired lot) had resolved. Not Provided          No concomitants and treatment drugs were provided.
Red, hot to the touch, swelling, wheezing, coughing, sore throat, congested, shortness of breath, pain from shoulder blade down to wrist.
This spontaneous report as received from Registered Nurse regarding multiple unspecified number of patients of unknown age and gender. The medical history of patients and their concurrent conditions were not reported. On unspecified dates, multiple unspecified number of patients were vaccinated with improperly stored doses of ROTATEQ (lot # L013206, expiry date 29-JAN-2017 and lot # K020182, expiry date 25-JUN-2016) dosage regimen and route unknown. Concomitant medications were not reported. No adverse effects were reported. Product quality complaint (PQC) was not filed. This report is one of the several reports received from the same reporter.  Additional information has been requested.
Patient arrived to pharmacy wanting the booster vaccination. We administered the Pfizer vaccine. When patient came back with his COVID vaccine card to update his initial vaccine series was MODERNA.  We failed to verify what his initial vaccine series was before giving the booster,
Severe nausea, chills, joint pain, muscle aches, headache, itching. Still have the rash from prior vaccination so have MD visit later today for the nausea and rash/itching.
nausea; My 6yr. Vomited twice after the first dose and has vomited 11 times since the second dose.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 6 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 24Jan2022 10:00 (Lot number: FL8094) at the age of 6 years as dose 2 (tris), single and administered in arm left, administration date 03Jan2022 10:00 (Lot number: FL0007) as dose 1 (tris), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: NAUSEA (non-serious) with onset 07Jan2022 07:00, outcome "not recovered", described as "nausea"; VOMITING (non-serious) with onset 07Jan2022 07:00, outcome "not recovered", described as "My 6yr. Vomited twice after the first dose and has vomited 11 times since the second dose.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of nausea, vomiting.  Additional information: Both my children (6yr & 8yr) received their Covid-19 vaccines the same day at the same pharmacy. They both are showing signs of vomiting. Once they vomit they feel fine. They aren't showing any other signs or symptoms of illness. The rest of our family continues to be healthy, but these two kids have been sick since they started with their vaccines. My 6yr. Vomited twice after the first dose and has vomited 11 times since the second dose. My 8yr has vomited 3 times with only the second dose. No other symptoms but nausea and vomiting on and off for both kids. These symptoms have been going on for weeks and the only thing I can trace it back to that they have in common is the vaccine. Nothing has been changed in their diet or medications since they received both doses.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200287282 same reporter drug AE different pt
cough got worse  runny nose  headache sore throat  chills body aches teeth sensitive  all these symptoms started Wednesday night which is the day I got the vaccine they lasted all Thursday and felt nothing on Friday
feverish a few hrs p/vax given APAP; high fever the next day (104); sitffened & jerked for about 10 seconds @ home; in ER given ATB; throat & ear infect; no further sz;
The patient was administered the vaccine in the left deltoid. The vaccinator documented that it was placed in the left bicep. After speaking to the vaccinator, they described the correct administration location and that they had completed a documentation error.
Swelling of left lymph node under jaw, salty taste in mouth, slight swelling of right lymph node under jaw, beginning around July 1, 2021  Went to Urgent Care and they prescribed antibiotic for 12 days and suggested getting ultrasound. Went to HCF   Dr  and she ordered an ultrasound. Ultrasound showed swollen lymph node with no hard cyst. Have a follow up scheduled in 4 months. Have salty taste in mouth on left side.
I had a headache for three weeks. I had a fever for almost three weeks. I was extremely tired - felt like I had mono had Body aches; joints ached horribly bad; arm was sore. Horrible abdominal pain and diarrhea and all of those symptoms was continuous for the first three weeks. I called my primary care doctor and My GI doctor. The GI doctor called me an anti-spasm medicine to help with intestinal pain I was having. Dicyclomine - that is what I got on. That was 10 mg three times a day - one before each meal. That did not suffice for the pain. I started those seven days before the second vaccine which was on July 28th. Last week, I had called back to GI doctor, and I told him I needed a steroid and he called me in a Entocort (steroid) - 3 mg. Started on August 17th. I take three in the morning. I am supposed to take it until I see the doctor again which will be 30 days. Two capsules four times a day - two before each meal and two before bed of the Dicyclomine. It has helped a lot to do these two now. It helps with some of the abdominal pain and with the diarrhea. I'm still very loose with stools but it's not diarrhea anymore. So, I've had some improvement.
Pain at injection site Pain in legs Very Tired Feeling like being stung by a bee.  This lasted about 15 minutes Cold or Allergy like feelings  Most of these issues unless time was about a day.  By Saturday I was still a bit tired but started to get back to normal.   Treatment was lots of rest, Drink water and Gatorade.    Please note:  states the vaccine was given in my left arm. I requested my right arm as that I am left handed.  This request was granted.
Patient did not have any events, but this vaccine is not approved for the patient's age. It was administered without the clinician noticing the patient's age.
tested positive for Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for Covid-19) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included VITAMINS NOS for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced COVID-19 (tested positive for Covid-19). At the time of the report, COVID-19 (tested positive for Covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Some hives showed up at the injection site about 4-5 minutes after the injection. The nurse there gave him a childrens' dose of Benadryl and in a few minutes they started clearing up and within 10 minutes the hives were all gone.
hives around injection site; rash around injection site; itchiness at injection site; warmth at injection site; bump at the injection site; A spontaneous report was received from a consumer concerning a 35-year-old, mfeale patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced injection site urticaria,injection site pruritis,injection site warmth,injection site mass and injection site rash.  The patient's medical history was unknown.. Concomitant medications were unknown. On 21-JAN-2021  prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011J20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 21-JAN-2021, prior to receiving mRNA-1273, the patient felt warmth and a bump at the injection site and went away followed by random itchiness  and on 27-JAN-2021 injection site warm and itchy surrounded by a rash and hives.  Treatment for the events was unknown. Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the events,injection site mass , were considered resolved  and outcome of injection site urticaria,injection site pruritis,injection site warmth,injection site rash were considered unknown.
Regeneron Casirivimab.  Developed hives about 15 minutes into the infusion.  Treated with solumedrol, Benadryl, Pepcid. Sent to the ED.
She is a 94 y.o. female patient of DO with history of GI bleed and diverticulosis who presented to the Hospital with complaint of diarrhea, LLQ discomfort and bright red blood in stool.  She had a recent NSTEMI a couple of weeks ago at which time DAPT was restarted.  She was found to have acute splenic flexure diverticulitis.  Acute diverticulitis History of diverticulosis. CT with acute splenic flexure diverticulitis. Blood Cx-no growth Continue Zosyn (day #3)- switch to oral antibiotics tomorrow- Cipro 500 mg oral daily and Flagyl 500 mg oral every 8 hours-for 7 days Pain management prn Monitor WBC  GI bleed Hematochezia Acute Anemia -blood loss Hgb 11.2> 10.1>10.3>9.0 Unremarkable EGD in 8/20/22, flex sig at that time showed sigmoid diverticulosis. Hold Plavix, continue aspirin. HOLD Plavix secondary to GI bleed- patient instructed to follow up with Cardiology to discuss re-starting this medication- patient wishes not to restart at this time due to bleeding Continue Protonix General surgery following- no indication for acute endoscopic intervention  Gastroenterology signed off- follow up with PCP Tolerating full liquid diet- advance as tolerated  Choledocholithiasis Noncontrast CT with choledocholithiasis within the distal common bile duct with common bile duct distention. Unremarkable hepatobiliary enzymes. GI evaluating, may not pursue ERCP as asymptomatic, and with advanced age. General surgery following-signed off no surgical intervention    Urinary bladder thickening Reviewed CT finding of urinary bladder thickening with surrounding fat stranding and intraluminal air. Patient reported bladder irrigation the day prior to presentation.   Monitor urine output and any urinary symptoms.   Leukocytosis WBC- 12.22>11.0>8.38 Afebrile Monitor CBC   Chronic combined systolic and diastolic CHF CAD Last 2D echo of 8/2022 with LVEF of 39%, grade 2 diastolic dysfunction. Recent NSTEMI 1/17/23 Continue medical management.-hold Plavix Daily weights Strict I & 0's   Essential hypertension Hyperlipidemia BP is controlled. Continue metoprolol, Zestril. Atorvastatin   AKI Creatinine of 1.49>1.31>1.45>1.51 Recent bladder irrigation. Avoid nephrotoxins. Monitor BMP Strict I & O's
RESIDENT INADVERTENTLY ADMINISTERED BOOSTER DOSE AFTER RECEIVING THE 3RD DOSE (IMMUNOCOMPROMISED) ON 8/26/21. DATES OF PFIZER VACCINE ADMINISTERED: 1/12/21, 2/2/21, 8/26/21, 10/6/21.
(acute urticaria) Hives on Torso, Upper Arms, Thighs, Legs, Buttocks beginning Day 6 and continuing and worsening
This spontaneous report was received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On unknown dates, the patients were vaccinated with improperly stored M-M-R II lot # M007279 with expiration date of 09-FEB-2018 and lot # M034857 with expiration date of 27-JUL-2018 (doses, route of administration and anatomical location were not provided) reconstituted with properly stored diluent MRK (lot # and expiration date were unknown). No adverse effects were reported. Administered doses of vaccine underwent the temperature excursion of 48.7 degrees Fahrenheit (F) for 13 hours which was detected by a data logger. There were no previous excursions reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1704USA009409: US-009507513-1704USA009410: US-009507513-1704USA002131.
intermittent dizziness poor balance, , loss of stamina , shortness of breath, foggy brain.
C/O chest pain, back pain, pelvic cramps starting 2 hours after vaccine given and continuing for next 24 hours. Called to report at that time.